Thursday, April 28, 2016 3:20:23 PM
• 04/22/2016 In the meantime, part of our team takes part in the exhibition in the framework of the Ural Forum 2016 in Yekaterinburg , we hasten to share upcoming events, which we are pleased to announce a portable ultrasound machine anesthesiologist eZono and system for adsorption CytoSorb cytokine . 15-17 May 2016 : We will take part in the exhibition at the XIII All-Russian scientific conference "Standards and individual approaches in anesthesia and resuscitation" in Gelendzhik . Our company is in the framework of this conference for several years in a rowultrasonic eZono system , and now we have to exclusives appeared system gemoadsorbtsii excessive cytokine levels to combat sepsis and septic shock CytoSorb production company CytoSobents Europe GmbH. Come to our stand with pleasure in detail describe the system! 3-4 June 2016:Representatives of our company will participate in the exhibition under the X Anniversary International Conference "Actual aspects of extracorporeal blood purification in intensive care" on the basis of the Scientific Center of Cardiovascular Surgery named . AN Bakuleva in cityMoscow . As the work in this area began not so long ago we did not have to take part in this event, but to participate in the Jubilee Conference particularly honorable. Your attention will be presented to the system cytokine adsorption to deal with sepsis and septic shock CytoSorb . Looking forward to seeing you at our ! stand also June 4 welcome to visit the lecture of Professor Hungarian Zsolt Molnera (of Zsolt Molnár) , that sanctify the following topics: 9.30-11.00: «love and Sepsis:? what's in common all» ( «Sepsis and love: what is common?") 15.15-16.45 : «the rationale and clinical benefit of cytokine removal in septic shock» (with the support of the company "CytoSorbents") ( «Scientific design and clinical substantiation remove cytokines in septic shock" (with the support of "CytoSorbents"))
18.4.2016 We are glad to inform you that our company will participate in the exhibition in the framework of the Ural Forum 2016 in Yekaterinburg , the main theme is "Modern problems of Anesthesiology and Intensive Care" . As before, we represent a modern ultrasound machine anesthesiologist eZono , the main features of which are the navigation system (built-in a unique completely Russified system guide that allows the doctor to quickly learn the specifics of nerve block and vascular access), as well as needle detection function (a system that allows "to lay the way "of the needle to the target in real time, especially if the needle is inserted outside the sensor plane). in addition, your attention will be presented to the modern technology of the adsorption of cytokines to fight sepsis and septic shock , unique within the Russian Federation, CytoSorb system manufactured by CytoSobents Europe GmbH . CytoSorb quickly reduce excessive levels of cytokine concentrations, significantly removes myoglobin, bilirubin, and free hemoglobin, but does not affect the electrolyte balance. It is suggested to visit the lecture of the Austrian Professor Klaus Georg Crenna (by Claus by Georg Krenn) , which is the head of the department of intensive care 13 C1 anesthesiology Department Faculty of general anesthesiology and pain therapy Medical University of Vienna, Austria, as well as vice-president of the Austrian society anesteziologii- resuscitation and IT (ÖGARI). His main areas of research: * Monitoring of hemodynamic and prevention of risks in the development of multiple organ failure, the support bodies with severe multiple organ failure and organ failure, solid organ transplantation. * Monitoring and ablative surgery in all types of patients in critical conditions, a special emphasis on the use of research in routine clinical practice. * Laboratory studies of the role of inflammation and apoptosis in the development of sepsis and organ failure and clinical significance of the parameters for its early identification and forecasting. * particular emphasis is placed on the use of techniques in clinical practice. Professor Krenn tells in detail about the development of signs of sepsis, severe sepsis and septic shock, what are the methods of struggle, will talk about a new therapy to combat sepsis, and will use the latest examples of cytokine adsorption system in clinical practice. We are looking forward to seeing you around our stand and answer any questions!
http://www.intensivmed.ru/index.php?option=com_content&view=category&layout=blog&id=6&Itemid=26&lang=en
Recent CTSO News
- CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference • GlobeNewswire Inc. • 08/27/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2024 08:51:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 10:58:42 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 10:57:45 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/16/2024 09:28:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 09:12:04 PM
- CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/16/2024 08:05:00 PM
- CytoSorbents Reports Second Quarter 2024 Financial and Operational Results • GlobeNewswire Inc. • 08/13/2024 08:19:55 PM
- CytoSorbents Appoints Peter J. Mariani Chief Financial Officer • GlobeNewswire Inc. • 08/13/2024 08:18:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:04:32 PM
- CytoSorbents to Report Second Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:12:56 PM
- CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 08/01/2024 11:00:00 AM
- CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website • GlobeNewswire Inc. • 07/29/2024 12:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/26/2024 09:14:03 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/26/2024 09:11:21 PM
- CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress • GlobeNewswire Inc. • 07/17/2024 11:00:00 AM
- CytoSorbents Secures $20 Million Credit Facility • GlobeNewswire Inc. • 07/02/2024 11:00:00 AM
- CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan • GlobeNewswire Inc. • 06/24/2024 11:00:00 AM
- CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union • GlobeNewswire Inc. • 06/13/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:31:20 PM
- CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting • GlobeNewswire Inc. • 06/05/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:35:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 09:23:00 PM
- CytoSorbents Reports First Quarter 2024 Results • GlobeNewswire Inc. • 05/09/2024 08:17:23 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM